News from KiTZ

In bad company: Immune cells in the tumor environment determine the success of treatment for childhood brain tumors

 

The cellular environment of a tumor can support or sabotage recovery. The most comprehensive study to date on the tumor microenvironment in low-grade…

Cancer cells of rare childhood brain tumors resemble immature brain cells

 

Cancer cells of a certain form of rare and aggressive brain tumors in infants and young children show characteristics of immature brain cells. This…

The origin of evil: stem cell-like cells are the reason for relapses of blood cancer in children and adolescents

 

Stem cell-like leukemia cells are responsible for relapses in children and adolescents with a certain type of blood cancer, T-ALL. Researchers at the…

Stefan Pfister admitted to Academia Europaea

 

KiTZ Director Stefan Pfister was elected to the European Academy of Sciences “Academia Europaea”. This promotes interdisciplinary European research…

Brain tumors in children: mapping vulnerabilities in dormant cancer cells

 

Some cancer cells escape treatment by entering a kind of ‘hibernation’. These cells promote resistance and can lead to relapses in certain childhood…

Novel laboratory models pave the way for targeted therapies for childhood sarcomas

 

Sarcomas in soft tissue also occur in young people and are particularly difficult to treat. Due to a lack of laboratory models, the causes of their…

Florists throughout Germany collect 122,553 euros for children's cancer research

 

Children and young people with cancer need better and child-friendly therapies. That's what the campaign “Give flowers. Spread hope.” campaign by the…

Childhood brain tumors develop early in highly specialized nerve cells

 

Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of…

Helping children with cancer with flowers

 

From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer.…

„Human Frontiers in Science“ funding for Franziska Blaeschke

 

Physician and scientist Franziska Blaeschke from KiTZ, Heidelberg University Hospital (UKHD) and the German Cancer Research Center (DKFZ) has been…